Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases

The iShares Nasdaq Biotechnology Index Fund and the SPDR S&P Biotech ETF have both gained over 25 percent year-to-date. Five Star Equities examines the outlook for companies in the Biotech Industry and provides equity research on Geron Corporation and Galena Biopharma Inc.

http://www.sys-con.com/node/2454049